First Time Loading...

Mochida Pharmaceutical Co Ltd
TSE:4534

Watchlist Manager
Mochida Pharmaceutical Co Ltd Logo
Mochida Pharmaceutical Co Ltd
TSE:4534
Watchlist
Price: 3 190 JPY -0.47% Market Closed
Updated: May 4, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

100.1B
+0.6%
Revenue
Growth Rates:
1 Year
-6%
3 Years
-2%
5 Years
-10%
7 Years
+7%
10 Years
+8%
3.9B
-45%
Operating Income
Growth Rates:
1 Year
-66%
3 Years
-66%
5 Years
-63%
7 Years
-70%
10 Years
-76%
3B
-46%
Net Income
Growth Rates:
1 Year
-64%
3 Years
-55%
5 Years
-69%
7 Years
-68%
10 Years
-70%

Earnings Waterfall
Mochida Pharmaceutical Co Ltd

Revenue
100.1B JPY
Cost of Revenue
-48.8B JPY
Gross Profit
51.3B JPY
Operating Expenses
-47.3B JPY
Operating Income
3.9B JPY
Other Expenses
-930m JPY
Net Income
3B JPY

Income Statement
Mochida Pharmaceutical Co Ltd

Rotate your device to view
Income Statement
Currency: JPY
Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023
Revenue
Revenue
92 291
N/A
93 947
+2%
92 015
-2%
91 037
-1%
89 529
-2%
87 252
-3%
89 467
+3%
90 200
+1%
92 138
+2%
92 272
+0%
94 138
+2%
93 337
-1%
93 140
0%
97 349
+5%
101 852
+5%
105 511
+4%
108 042
+2%
106 761
-1%
107 550
+1%
109 409
+2%
110 669
+1%
109 643
-1%
106 331
-3%
103 919
-2%
101 102
-3%
101 799
+1%
102 690
+1%
101 910
-1%
102 583
+1%
102 995
+0%
102 978
0%
105 381
+2%
107 928
+2%
110 179
+2%
110 509
+0%
109 370
-1%
106 759
-2%
103 261
-3%
100 316
-3%
99 537
-1%
100 085
+1%
Gross Profit
Cost of Revenue
(33 974)
(34 364)
(33 972)
(33 940)
(34 220)
(33 913)
(35 013)
(35 921)
(36 806)
(37 273)
(37 918)
(37 386)
(36 673)
(41 043)
(44 921)
(49 341)
(53 042)
(53 182)
(53 898)
(55 516)
(57 410)
(55 477)
(53 729)
(51 469)
(49 084)
(49 882)
(50 510)
(49 458)
(48 546)
(48 203)
(47 630)
(48 791)
(49 255)
(50 626)
(50 654)
(50 318)
(49 862)
(48 146)
(47 254)
(47 336)
(48 800)
Gross Profit
58 317
N/A
59 583
+2%
58 043
-3%
57 097
-2%
55 309
-3%
53 339
-4%
54 454
+2%
54 279
0%
55 332
+2%
54 999
-1%
56 220
+2%
55 951
0%
56 467
+1%
56 306
0%
56 931
+1%
56 170
-1%
55 000
-2%
53 579
-3%
53 652
+0%
53 893
+0%
53 259
-1%
54 166
+2%
52 602
-3%
52 450
0%
52 018
-1%
51 917
0%
52 180
+1%
52 452
+1%
54 037
+3%
54 792
+1%
55 348
+1%
56 590
+2%
58 673
+4%
59 553
+1%
59 855
+1%
59 052
-1%
56 897
-4%
55 115
-3%
53 062
-4%
52 201
-2%
51 285
-2%
Operating Income
Operating Expenses
(42 026)
(42 983)
(43 090)
(44 164)
(43 510)
(42 361)
(41 621)
(39 799)
(40 704)
(42 845)
(44 661)
(43 625)
(43 204)
(44 932)
(43 720)
(43 939)
(44 505)
(41 917)
(41 777)
(42 698)
(42 520)
(43 576)
(43 660)
(43 282)
(44 361)
(43 110)
(43 298)
(42 616)
(42 399)
(42 789)
(44 756)
(45 685)
(44 809)
(45 161)
(45 033)
(45 512)
(45 194)
(46 608)
(46 305)
(45 021)
(47 343)
Selling, General & Administrative
(42 022)
(31 026)
(43 100)
(44 170)
(43 522)
(29 881)
(40 908)
(39 795)
(40 698)
(29 391)
(44 271)
(43 637)
(43 218)
(29 710)
(43 715)
(43 933)
(44 492)
(29 992)
(41 761)
(42 682)
(42 514)
(30 581)
(43 668)
(43 287)
(44 369)
(31 228)
(43 302)
(42 624)
(42 401)
(31 939)
(44 756)
(45 683)
(44 816)
(32 866)
(44 381)
(45 513)
(45 194)
(33 324)
(46 304)
(45 021)
(47 342)
Research & Development
0
(11 961)
0
0
0
(11 777)
0
0
0
0
0
0
0
(15 226)
0
0
0
(11 912)
0
0
0
(13 003)
0
0
0
(11 884)
0
0
0
(10 849)
0
0
0
(12 295)
0
0
0
(13 283)
0
0
0
Other Operating Expenses
(4)
4
10
6
11
(703)
(713)
(4)
(6)
(13 454)
(390)
11
13
4
(5)
(6)
(13)
(13)
(16)
(16)
(6)
8
8
5
8
2
4
8
2
(1)
0
(2)
7
0
(652)
1
0
(1)
(1)
0
(1)
Operating Income
16 291
N/A
16 600
+2%
14 953
-10%
12 933
-14%
11 799
-9%
10 978
-7%
12 833
+17%
14 480
+13%
14 628
+1%
12 154
-17%
11 559
-5%
12 326
+7%
13 263
+8%
11 374
-14%
13 211
+16%
12 231
-7%
10 495
-14%
11 662
+11%
11 875
+2%
11 195
-6%
10 739
-4%
10 590
-1%
8 942
-16%
9 168
+3%
7 657
-16%
8 807
+15%
8 882
+1%
9 836
+11%
11 638
+18%
12 003
+3%
10 592
-12%
10 905
+3%
13 864
+27%
14 392
+4%
14 822
+3%
13 540
-9%
11 703
-14%
8 507
-27%
6 757
-21%
7 180
+6%
3 942
-45%
Pre-Tax Income
Interest Income Expense
111
114
137
80
100
116
290
323
360
350
278
279
183
181
117
116
219
220
201
187
228
472
246
261
206
239
222
211
196
155
707
718
788
812
275
269
236
304
226
265
285
Non-Reccuring Items
(981)
(1 012)
1
0
0
0
0
(1 109)
(1 109)
(397)
0
0
0
0
0
0
0
0
1 557
1 557
1 557
615
(683)
(680)
(680)
(2 991)
(2 969)
(2 972)
(3 108)
(252)
(355)
(385)
(354)
(728)
0
(612)
(505)
13
24
15
1
Gain/Loss on Disposition of Assets
(12)
(10)
(11)
(12)
(26)
(57)
(57)
(69)
(79)
0
(52)
(35)
(30)
(64)
(65)
(88)
124
108
105
125
(76)
(154)
(151)
(182)
(179)
108
109
84
0
(108)
(111)
(56)
(56)
(5)
(6)
(42)
(45)
(54)
(84)
(44)
(41)
Total Other Income
126
114
118
97
97
104
85
113
35
(10)
55
43
109
92
99
109
102
126
121
116
126
119
119
135
137
110
121
101
188
102
121
158
152
120
98
55
52
274
279
265
293
Pre-Tax Income
15 535
N/A
15 806
+2%
15 198
-4%
13 098
-14%
11 970
-9%
11 141
-7%
13 151
+18%
13 738
+4%
13 835
+1%
12 097
-13%
11 840
-2%
12 613
+7%
13 525
+7%
11 583
-14%
13 362
+15%
12 368
-7%
10 940
-12%
12 116
+11%
13 859
+14%
13 180
-5%
12 574
-5%
11 642
-7%
8 473
-27%
8 702
+3%
7 141
-18%
6 273
-12%
6 365
+1%
7 260
+14%
8 914
+23%
11 900
+33%
10 954
-8%
11 340
+4%
14 394
+27%
14 591
+1%
15 189
+4%
13 210
-13%
11 441
-13%
9 044
-21%
7 202
-20%
7 681
+7%
4 480
-42%
Net Income
Tax Provision
(5 364)
(5 913)
(5 324)
(4 512)
(4 087)
(3 597)
(4 328)
(4 475)
(4 387)
(3 946)
(3 613)
(3 715)
(3 976)
(3 057)
(3 793)
(3 482)
(2 939)
(3 092)
(3 311)
(3 142)
(2 972)
(3 207)
(2 576)
(2 612)
(2 177)
(1 675)
(1 705)
(1 843)
(2 286)
(3 312)
(3 079)
(3 246)
(4 034)
(4 022)
(4 119)
(3 635)
(2 970)
(2 395)
(2 020)
(2 116)
(1 469)
Income from Continuing Operations
10 171
9 893
9 874
8 586
7 883
7 544
8 823
9 263
9 448
8 151
8 227
8 898
9 549
8 526
9 569
8 886
8 001
9 024
10 548
10 038
9 602
8 435
5 897
6 090
4 964
4 598
4 660
5 417
6 628
8 588
7 875
8 094
10 360
10 569
11 070
9 575
8 471
6 649
5 182
5 565
3 011
Net Income (Common)
10 171
N/A
9 892
-3%
9 872
0%
8 585
-13%
7 881
-8%
7 544
-4%
8 823
+17%
9 262
+5%
9 449
+2%
8 150
-14%
8 226
+1%
8 897
+8%
9 547
+7%
8 526
-11%
9 569
+12%
8 886
-7%
8 001
-10%
9 023
+13%
10 548
+17%
10 037
-5%
9 602
-4%
8 435
-12%
5 897
-30%
6 091
+3%
4 964
-19%
4 598
-7%
4 660
+1%
5 417
+16%
6 627
+22%
8 587
+30%
7 873
-8%
8 092
+3%
10 360
+28%
10 569
+2%
11 071
+5%
9 576
-14%
8 470
-12%
6 649
-21%
5 182
-22%
5 564
+7%
3 012
-46%
EPS (Diluted)
254.27
N/A
247.3
-3%
246.8
0%
214.62
-13%
197.02
-8%
188.63
-4%
220.57
+17%
231.55
+5%
236.22
+2%
205.22
-13%
205.65
+0%
222.42
+8%
238.67
+7%
214.72
-10%
239.22
+11%
222.15
-7%
200.02
-10%
227.26
+14%
263.7
+16%
250.92
-5%
241.85
-4%
212.86
-12%
150.32
-29%
155.26
+3%
126.9
-18%
117.55
-7%
120.24
+2%
139.78
+16%
171.56
+23%
222.27
+30%
205.72
-7%
211.46
+3%
271.5
+28%
277.39
+2%
294.68
+6%
255.85
-13%
228.88
-11%
178.93
-22%
141.92
-21%
154.94
+9%
84.7
-45%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.